|
|
||||||||
Ann Thorac Surg 2002;74:876-884
© 2002 The Society of Thoracic Surgeons
a Division of General Thoracic Surgery, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
b Section of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
* Address reprint requests to Dr Miller, Emory University Clinic, 1365 Clifton Road NE, Atlanta, GA, USA 30322
e-mail: daniel_miller{at}emoryhealthcare.org
Presented at the Forty-eighth Annual Meeting of the Southern Thoracic Surgical Association, San Antonio, TX, Nov 810, 2001.
Background. The purpose of this report is to analyze preoperative and perioperative factors affecting operative mortality and cardiopulmonary morbidity after a completion pneumonectomy.
Methods. We retrospectively reviewed all patients who underwent completion pneumonectomy from January 1985 through September 1998 at the Mayo Clinic in Rochester, MN. Factors affecting operative mortality and postoperative morbidity and were analyzed using univariate and multivariate analysis.
Results. There were 115 patients (73 men and 42 women), with a median age of 64 years (range, 12 to 83 years). Indication for pneumonectomy was benign disease in 57 patients (49.6%), lung cancer in 51 (44.3%) and metastatic disease in 7 (6.1%). There were 24 deaths (mortality 20.9%, 95% CI 13.9% to 29.4%). Mortality for patients undergoing completion pneumonectomy for benign disease, lung cancer, and metastatic cancer was 26.3%, 17.6%, and 0%, respectively (p = 0.24). Factors adversely affecting mortality with univariate analysis included advanced age (p = 0.004), preoperative corticosteriod use (p = 0.01), decreased preoperative diffusion capacity of lung to carbon monoxide (p = 0.01), intraoperative blood transfusion (p = 0.04), and excessive crystalloid infusion within the first 12 hours (p = 0.01) and 24 hours (0.03) postoperatively, respectively. Factors adversely affecting mortality with multivariate analysis included advanced age (p = 0.001), preoperative corticosteriod use (p = 0.002), and low preoperative hemoglobin (p = 0.02). Cardiopulmonary complications occurred in 72 patients (63.7%). Factors adversely affecting morbidity with univariate analysis included benign disease (p = 0.002), decreased preoperative diffusion capacity of lung to carbon monoxide (p = 0.04), bronchial stump reinforcement (p = 0.0001), and excessive crystalloid infusion within the first 12 hours (p = 0.006) and 24 hours (p = 0.02) postoperatively, respectively. Factors adversely affecting morbidity with multivariate analysis included advanced age (p = 0.005) and bronchial stump reinforcement (p = 0.001).
Conclusions. Multiple factors adversely affect operative mortality and cardiopulmonary morbidity after completion pneumonectomy. Although completion pneumonectomy remains a high-risk procedure, especially for benign disease, it still should be considered a treatment option in selected patients.
This article has been cited by other articles:
![]() |
A.-M. Hamad, G. Marulli, M. Schiavon, and F. Rea A completion sleeve bilobectomy for nonstump postlobectomy bronchopleural fistula. Ann. Thorac. Surg., June 1, 2008; 85(6): 2112 - 2114. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Chataigner, E. Fadel, B. Yildizeli, A. Achir, S. Mussot, D. Fabre, O. Mercier, and P. G. Dartevelle Factors affecting early and long-term outcomes after completion pneumonectomy Eur. J. Cardiothorac. Surg., May 1, 2008; 33(5): 837 - 843. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nakanishi, A. Hirai, T. Yamashita, and S. Oka Video-assisted thoracoscopic completion pneumonectomy for a second primary cancer: A case report. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 945 - 946. [Full Text] [PDF] |
||||
![]() |
P. A. Linden, B. Y. Yeap, M. Y. Chang, W. G. Henderson, M. T. Jaklitsch, S. Khuri, D. J. Sugarbaker, and R. Bueno Morbidity of Lung Resection After Prior Lobectomy: Results from the Veterans Affairs National Surgical Quality Improvement Program Ann. Thorac. Surg., February 1, 2007; 83(2): 425 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shaw Genetics of postoperative complications following thoracic surgery. Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 327 - 345. [Abstract] [PDF] |
||||
![]() |
J. T. Sherwood, J. D. Mitchell, and M. Pomerantz Completion pneumonectomy for chronic mycobacterial disease J. Thorac. Cardiovasc. Surg., June 1, 2005; 129(6): 1258 - 1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Jungraithmayr, J. Hasse, M. Olschewski, and E. Stoelben Indications and results of completion pneumonectomy Eur. J. Cardiothorac. Surg., July 1, 2004; 26(1): 189 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Guggino, C. Doddoli, F. Barlesi, P. Acri, B. Chetaille, P. Thomas, R. Giudicelli, and P. Fuentes Completion pneumonectomy in cancer patients: experience with 55 cases Eur. J. Cardiothorac. Surg., March 1, 2004; 25(3): 449 - 455. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |